probiome Sign in
← Conditions Heart, blood and vessels Genus-level

Coronary heart disease

Compared within 2 studies that had both: 48 people with coronary heart disease and 50 healthy people. No genera less common in people with coronary heart disease, and none more common.

A difference is an association: it doesn’t mean these genera cause, prevent or treat coronary heart disease. GMrepo reports this group at the genus level only, so these are genera, not species.

Searching opens both lists and shows only matching rows.

Less common in coronary heart disease · 0

Strongest first, then the biggest gap · Each figure is 10 people Strongest first · Each figure is 10 people

None compared.

More common in coronary heart disease · 0

Strongest first, then the biggest gap · Each figure is 10 people Strongest first · Each figure is 10 people

None compared.

Where these numbers come from

Studies
Only GMrepo projects that had people with the condition and healthy people, 10 or more of each. Numbers come from those studies, never from pooling.Sampled in China.
How common
The share of people whose sample has any of it, in the people with the condition and in the healthy people of those same studies. Tested within studies (Cochran–Mantel–Haenszel, corrected for testing many microbes); a difference counts when it is clear and meaningful (Cohen’s h of 0.2 or more).
Strength word
Counted by code from how many studies point the same way: Seen again and again (3 or more, none clearly the other way), Seen more than once (2, the majority), Seen once (1, listed last). Where studies disagree, a row isn’t listed.
Each study
Tap a row for every study’s own numbers, and for how much carriers have.
Analysis
Our analysis of GMrepo data. GMrepo on Data sources · Read the rules

Also compared · 150 genera

Compared within studies that had both, but not listed above.

No meaningful difference · 150
PubMed · human studies and reviews first

Recent research

All research on it
  1. Phytomedicine · 2026
    Huangjin Shuangshen Jiawei decoction alleviated coronary heart disease comorbid with depression partly through gut microbiota-mediated regulation of the SRSF1-p53-ASPP1 signaling axis.
    PubMed ↗
  2. Probiotics and antimicrobial proteins · 2024
    An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD).
    PubMed ↗
  3. Frontiers in cellular and infection microbiology · 2022
    Regional pattern and signatures of gut microbiota in rural residents with coronary heart disease: A metagenomic analysis.
    PubMed ↗
  4. BMC genomics · 2019
    Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease.
    PubMed ↗
  5. Randomized trial Probiotics and antimicrobial proteins · 2019
    The Effects of Synbiotic Supplementation on Carotid Intima-Media Thickness, Biomarkers of Inflammation, and Oxidative Stress in People with Overweight, Diabetes, and Coronary Heart Disease: a Randomized, Double-Blind, Placebo-Controlled Trial.
    PubMed ↗

Source: PubMed, U.S. National Library of Medicine · 5 linked papers, last 10 years